CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Cornucopian Capital
United States
- Montclair, NJ
- 18/04/2024
- Unknown
- $3,000,000
We believe that the emergence of Medicine 3.0 – predicative, preventative, personalized, and participatory healthcare – presents an untapped opportunity to build companies focused on effectively delivering customized health outcomes in new and innovative ways. These companies – which we call Precision Health Brands™ – will combine new technologies and scientific insight to significantly improve patient-consumer engagement, building the foundation of a new, proactive paradigm for health: whenever possible, prevent disease rather than wait to cure it.
- Industry Investment Management
- Website https://cornucopiancapital.com/
- LinkedIn https://www.linkedin.com/company/cornucopiancapital/
Related People
Aryeh GanzFounder
United States -
New York City Metropolitan Area
Investing in preventative health and scientific wellness - I'm building and supporting technology companies that use bio-measurement and personalized data, AI integration and engagement platforms, and bioactive ingredients - to improve healthspan, performance, and longevity.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)